Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins

Asian Pac J Cancer Prev. 2012;13(6):2699-703. doi: 10.7314/apjcp.2012.13.6.2699.

Abstract

The functional significance of the proteasome activator REGγ in the regulation of cell proliferation and apoptosis has been recognized. However, pathological contributions to tumor development remain to be elucidated. Both oncogenic proteins and tumor suppressors are targeted by REGγ for proteasomal degradation. It has been proposed that the role of the REGγ in the pathogenesis of cancer is cell- and context-specific. In this study, we aimed to explore the potential involvement of REGγ in laryngeal carcinomas, comparing protein expression in tumor and adjacent tissues by immunohistochemical staining and Western blot analysis. We also characterized the correlation between the expression of REGγ and the previously identified substrates p53 and p21. We showed that REGγ was abnormally highly expressed in cancer tissues. Statistical analysis revealed that there was a positive relationship between the level of REGγ and the expression of p53 and p21. Our study suggests that REγ overexpression can facilitate the growth of laryngeal cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apoptosis
  • Autoantigens / biosynthesis*
  • Autoantigens / metabolism
  • Cell Proliferation
  • Cyclin-Dependent Kinase Inhibitor p21 / biosynthesis*
  • Humans
  • Laryngeal Neoplasms / metabolism*
  • Male
  • Middle Aged
  • Proteasome Endopeptidase Complex / biosynthesis*
  • Proteasome Endopeptidase Complex / metabolism
  • Tumor Suppressor Protein p53 / biosynthesis*
  • Tumor Suppressor Proteins / metabolism

Substances

  • Autoantigens
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Ki antigen
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Proteasome Endopeptidase Complex